Impact of a new combined immunosuppressive regimen on the one-year follow-up of kidney transplant patients : a cost-effectiveness analysis

Details

Request a copy
Serval ID
serval:BIB_464C9662A70E
Type
A Master's thesis.
Collection
Publications
Institution
Title
Impact of a new combined immunosuppressive regimen on the one-year follow-up of kidney transplant patients : a cost-effectiveness analysis
Author(s)
Kast-Brückner Mira
Director(s)
Wasserfallen Jean-Blaise
Publisher
IEMS (Institute of Health Economics and Management)
Institution details
Université de Lausanne, Faculté des hautes études commerciales
Address
Lausanne
Publication state
Accepted
Issued date
2006
Genre
Mémoire / Institute of Health Economics and Management ; no 98
Language
french
Number of pages
26 f.
Notes
DESS en économie et management de la santé - Master in Health Economics and Management (MHEM) Mention de responsabiblité : / Mira Kast-Brückner ; [supervisor: Jean-Blaise Wasserfallen] SAPHIRID:62630
Abstract
[...] The objective of this study was to compare costs and efficacy of two different drug regimens in a Swiss hospital setting throughout the first year after renal transplantation: a new combined immunosuppressive and anti-infectious regimen and usual immunosuppression with anti-infectious prophylaxis reserved to high-risk patients. Thus, the main difference between the two drug regimens is the universal use of CMV [cytomegalovirus] prophylaxis for all patients. Applying the local cost structure, we compared resource use and direct short term costs associated with both hospital and outpatient care. We compared both regimens in terms of clinical outcomes, measured as the number of acute rejections and CMV infection episodes and related costs to clinical outcomes. [...] [Auteure p. 1-2]
Keywords
Kidney Transplantation , Immunosuppression , Cytomegalovirus Infections , Cost-Benefit Analysis , Hospitals, University
Create date
14/03/2008 11:12
Last modification date
20/08/2019 14:51
Usage data